AR 9281

Known as: AR-9281, AR9281 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2009-2011
01220092011

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
AR9281, a potent and selective inhibitor of soluble epoxide hydrolase (s-EH), is in clinical development targeting hypertension… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2012
2012
BACKGROUND AND AIMS This study evaluated the responses to soluble epoxide hydrolase (s-EH) inhibition, an essential enzyme in the… (More)
Is this relevant?
2011
2011
Endothelial dysfunction is a hallmark of, and plays a pivotal role in the pathogenesis of cardiometabolic diseases, including… (More)
Is this relevant?
2011
2011
1-(1-Acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea 14a (AR9281), a potent and selective soluble epoxide hydrolase inhibitor, was… (More)
  • table 1
  • figure 1
Is this relevant?
2009
2009
Soluble epoxide hydrolase inhibitors (sEHIs) are demonstrating promise as potential pharmaceutical agents for the treatment of… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
Is this relevant?